_edited.png){kind=small}
_edited.png)
THE ALBORADA TRUST DONATES £10M TO CANCER RESEARCH TO HELP DEVELOP THE NEXT GENERATION OF CANCER RESEARCH LEADERS
Established in 2001 by philanthropist Kirsten Rausing CBE, The ALBORADA Trust supports a wide range of charitable causes in the UK and internationally. The ALBORADA Trust has a longstanding relationship with Cancer Research UK having supported the work of the charity since 2005. Previous funding has included support for research infrastructure at the Cancer Research UK Cambridge Institute and an MB-PhD studentship through the Borysiewicz Clinical PhD Fund, which helps develop the next generation of clinician scientists.
To mark the 25th anniversary of The ALBORADA Trust has committing an unprecedented total of £10 million to support cancer research this year: The ALBORADA Trust has committed £9m to Cancer Research UK, enabling the charity to fund a new cohort of Career Development Fellows and help develop the next generation of cancer research leaders. It has also committed £1m to Addenbrooke's Charitable Trust (ACT) in support of its new Cambridge Cancer Research Hospital bringing its total investment in cancer research and care to £10m. One of the largest single philanthropic gifts to Cancer Research UK's £400m philanthropy campaign, More Research, Less Cancer, the donation will fund six CRUK – ALBORADA Fellowships. Cancer Research UK will match the Trust's commitment, creating a total investment of £18m and 12 Fellowships. The Fellowships will support exceptional researchers at a critical point in their careers, helping them establish independent research programmes, pursue ambitious ideas and build the skills, teams and expertise needed to become leaders in cancer research. Developing future research leaders through its philanthropic campaign is a strategic priority for Cancer Research UK. By investing in talented researchers, the charity is helping ensure the UK remains at the forefront of cancer research and innovation.
The ALBORADA Trust has, since its inception, distributed over c. £60 million. This long-term award to Cancer research in the UK will take the funding to c. £70m.
